-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R3fW6K4CyymJohI5iHnV44J5nU3n5REEN/QuMaeijIcVcAk4KOwAxWy7v+p25msT 8X36cMCD9UuOkZDnu14MaA== 0001230295-05-000072.txt : 20050519 0001230295-05-000072.hdr.sgml : 20050519 20050519091422 ACCESSION NUMBER: 0001230295-05-000072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050517 FILED AS OF DATE: 20050519 DATE AS OF CHANGE: 20050519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gyenes Lawrence A CENTRAL INDEX KEY: 0001301629 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 05843380 BUSINESS ADDRESS: BUSINESS PHONE: 732 418 9300 MAIL ADDRESS: STREET 1: C/O SAVIENT PHARMACEUTICALS, INC. STREET 2: ONE TOWER CENTER BLVD., 14TH FLOOR CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 4 1 gye1.xml X0202 4 2005-05-17 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001301629 Gyenes Lawrence A C/O SAVIENT PHARMACEUTICALS INC. ONE TOWER CENTER BLVD., 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 SVP, Chief Financial Officer Common Stock, $.01 par value per share 2005-05-17 4 P 0 1100 3.0700 A 30500.00 D Common Stock, $.01 par value per share 2005-05-17 4 P 0 9100 3.0800 A 39600.00 D Common Stock, $.01 par value per share 2005-05-17 4 P 0 3900 3.0600 A 43500.00 D Common Stock, $.01 par value per share 2005-05-17 4 P 0 900 3.0900 A 44400.00 D By: Beata A. Smith as Attorney-In-Fact for 2005-05-19 -----END PRIVACY-ENHANCED MESSAGE-----